Role Definition
| Field | Value |
|---|---|
| Job Title | Medical Device Software Engineer |
| Seniority Level | Mid-Senior (5-10 years) |
| Primary Function | Designs, develops, and maintains software for regulated medical devices under IEC 62304 lifecycle processes. Performs ISO 14971 risk management activities including software FMEA and hazard analysis. Produces FDA-compliant design control documentation — software requirements specifications, architecture documents, V&V protocols, traceability matrices, and Design History Files. Works on embedded device software, SaMD applications, or clinical system integrations across safety classes A-C. |
| What This Role Is NOT | Not a general Software Engineer (no regulatory overhead — scored 55.4 Green). Not a Firmware Engineer (bare-metal C/MCU focus without medical regulatory framework — scored 54.1 Green). Not a Biomedical Engineer (hardware/mechanical device design, not primarily software). Not a Regulatory Affairs Specialist (owns submission strategy, not software development). |
| Typical Experience | 5-10 years. Typically holds BSc/MSc in Software Engineering, Computer Science, or Biomedical Engineering. Proficient in C/C++, Python, or C# depending on device type. Deep familiarity with IEC 62304, ISO 14971, FDA 21 CFR 820 (QSR), and increasingly IEC 81001-5-1 (health software security). May hold certifications in quality systems or regulatory affairs. |
Seniority note: Junior medical device software engineers (0-3 years) writing code under close supervision with limited regulatory ownership would score lower — likely high Yellow, as AI handles boilerplate documentation and standard V&V patterns. Principal/Staff engineers who define software safety classification, own risk management files, and lead FDA submission strategy would score higher Green (Stable) due to irreducible accountability and judgment requirements.
Protective Principles + AI Growth Correlation
| Principle | Score (0-3) | Rationale |
|---|---|---|
| Embodied Physicality | 1 | Some V&V testing requires physical interaction with medical device hardware — bench testing, hardware-in-the-loop validation, clinical environment simulation. But the majority of work is desk-based software development and documentation. |
| Deep Interpersonal Connection | 1 | Cross-functional collaboration with clinical, regulatory, quality, and hardware teams is essential. Understanding clinical workflows requires human dialogue. But the core value is technical-regulatory output, not the relationship itself. |
| Goal-Setting & Moral Judgment | 2 | Defines software safety classification (IEC 62304 Class A/B/C), makes risk acceptability judgments (ISO 14971), decides whether residual risks are tolerable given clinical benefit. These are ethical-clinical-engineering judgment calls that directly affect patient safety. Not pure execution — genuine judgment in ambiguous situations. |
| Protective Total | 4/9 | |
| AI Growth Correlation | 1 | AI/ML is creating new demand for medical device software engineers — SaMD incorporating AI requires IEC 62304-compliant development, FDA AI/ML guidance compliance, and validation of adaptive algorithms. The FDA has cleared ~1,000 AI/ML-enabled devices as of 2025. More AI in healthcare = more regulated software = more demand for engineers who understand both. Weak positive, not strong — AI creates adjacent work rather than defining the role. |
Quick screen result: Protective 4 + Correlation positive = Likely Green Zone. Strong regulatory judgment and growing SaMD demand suggest comfortable Green. Proceed to quantify.
Task Decomposition (Agentic AI Scoring)
| Task | Time % | Score (1-5) | Weighted | Aug/Disp | Rationale |
|---|---|---|---|---|---|
| IEC 62304 lifecycle documentation & design controls | 20% | 3 | 0.60 | AUGMENTATION | Q2: AI generates document templates, populates SRS sections from requirements databases, and drafts design control records. Human leads — defines software safety class, ensures clinical intent is captured, reviews for regulatory sufficiency. AI accelerates but cannot own compliance sign-off. |
| Software architecture & detailed design (SaMD/embedded) | 20% | 2 | 0.40 | AUGMENTATION | Q2: AI assists with code generation and standard design patterns. Human architects safety-critical systems, makes trade-offs between performance/safety/regulatory burden, designs fault-tolerant architectures. Novel clinical algorithms and safety-class C architectures require human engineering judgment. |
| ISO 14971 risk management & FMEA | 15% | 2 | 0.30 | AUGMENTATION | Q2: AI can populate FMEA templates and suggest failure modes from databases. Human identifies software-specific hazards, assesses clinical severity, determines risk acceptability against benefit, and designs risk controls. Clinical risk judgment is irreducible — patient safety decisions require human accountability. |
| Verification & validation (V&V) testing | 15% | 2 | 0.30 | AUGMENTATION | Q2: AI generates unit tests, automates regression suites, and assists with test protocol drafting. Human designs validation strategies, executes hardware-in-the-loop testing with physical devices, and signs V&V reports. FDA requires documented human review of V&V evidence. Physical device testing cannot be automated. |
| FDA submission documentation (510(k)/PMA/DHF) | 10% | 2 | 0.20 | AUGMENTATION | Q2: AI drafts submission sections and compiles Design History Files from project artefacts. Human ensures clinical and regulatory accuracy, makes predicate device comparisons, and owns the submission narrative. FDA reviewers hold the manufacturer accountable — a human must stand behind the filing. |
| Code review & traceability matrix maintenance | 10% | 3 | 0.30 | AUGMENTATION | Q2: AI performs static analysis, identifies coding standard violations, and auto-generates traceability links. Human reviews for clinical correctness, validates that risk controls are properly implemented in code, and ensures traceability is complete. AI handles the mechanical linking; human validates the clinical meaning. |
| Cross-functional collaboration (HW, clinical, regulatory) | 5% | 1 | 0.05 | NOT INVOLVED | Design reviews with clinical teams, hardware integration discussions, regulatory strategy meetings. Human-to-human collaboration where clinical context, device history, and institutional knowledge are exchanged. AI not involved in these interactions. |
| CAPA & post-market surveillance activities | 5% | 2 | 0.10 | AUGMENTATION | Q2: AI flags complaint trends and assists with root cause analysis documentation. Human investigates software-related field failures, determines if safety corrections are needed, and makes CAPA decisions that may trigger FDA reporting. Accountability for patient safety corrections is irreducible. |
| Total | 100% | 2.25 |
Task Resistance Score: 6.00 - 2.25 = 3.75/5.0
Displacement/Augmentation split: 0% displacement, 95% augmentation, 5% not involved.
Reinstatement check (Acemoglu): Yes. AI creates significant new tasks: validating AI/ML algorithms embedded in medical devices, ensuring FDA AI/ML guidance compliance for adaptive algorithms, developing continuous learning system monitoring frameworks, and auditing algorithmic bias in clinical decision support software. The medical device software engineer who understands both IEC 62304 and ML model validation is an emerging and growing sub-role.
Evidence Score
| Dimension | Score (-2 to 2) | Evidence |
|---|---|---|
| Job Posting Trends | 1 | Indeed shows 279 active IEC 62304-specific medical device jobs (March 2026). Healthcare IT market valued at $142.3 billion drives sustained demand. SaMD postings growing as FDA clears more AI/ML devices (~1,000 cumulative). Not at acute shortage levels but steady growth across Stryker, Medtronic, Boston Scientific, Philips, and digital health startups. |
| Company Actions | 1 | Major medtech companies actively hiring — Stryker, Medtronic, Abbott, and Philips all expanding software teams for connected devices and SaMD. No medtech companies cutting software engineers citing AI. Digital health startups raising capital for AI-powered medical devices requiring IEC 62304-compliant development. Industry investing in software capability, not reducing it. |
| Wage Trends | 1 | ZipRecruiter reports $133,490 average (up to $205,000 for senior). Glassdoor shows competitive ranges $120K-$173K mid-level. Healthcare IT salary guides cite 3-5% YoY growth with premiums for regulatory expertise and AI/ML skills. Growing above inflation but not surging — consistent with broader senior software engineering trends. |
| AI Tool Maturity | 1 | AI tools (Copilot, Cursor) assist with code generation and documentation drafting. AI-powered validation tools emerging (Medium, 2026: "AI-Powered Medical Software Validation"). However, no production tools automate the regulatory judgment layer — safety classification, risk acceptability decisions, V&V sign-off, or FDA submission ownership. Tools augment productivity but cannot replace the regulatory-clinical decision-maker. |
| Expert Consensus | 1 | Broad agreement that medical device software engineering transforms but does not diminish. AttractGroup (2026): IEC 62304 lifecycle requires "traceable requirements, documented architecture decisions, test evidence tied to risk" — human accountability throughout. FDA AI/ML guidance mandates human oversight of AI-enabled devices. Expert view: the role evolves toward AI/ML validation expertise while core regulatory accountability persists. |
| Total | 5 |
Barrier Assessment
Reframed question: What prevents AI execution even when programmatically possible?
| Barrier | Score (0-2) | Rationale |
|---|---|---|
| Regulatory/Licensing | 2 | IEC 62304 mandates documented software lifecycle activities with human accountability. FDA 21 CFR 820 design controls require human sign-off at each stage. EU MDR and AI Act impose additional human oversight requirements for high-risk AI medical devices. The regulatory framework explicitly requires human engineers — AI cannot be the responsible party for a 510(k) submission or a risk management file. |
| Physical Presence | 1 | V&V testing with physical medical devices — hardware-in-the-loop, bench testing, clinical simulation environments — requires hands-on interaction. Not all tasks (60-70% is desk-based coding/documentation), but validation cannot be fully virtualised for implantable, surgical, or diagnostic hardware. |
| Union/Collective Bargaining | 0 | No significant union protection for medical device software engineers. At-will employment in US medtech. |
| Liability/Accountability | 2 | Medical device software failures can cause patient injury or death. Product recalls, FDA warning letters, consent decree actions, and personal criminal liability (Park Doctrine) create irreducible human accountability. A manufacturer must designate responsible individuals for device safety — AI has no legal personhood. The liability barrier is strong and structural, not temporal. |
| Cultural/Ethical | 1 | Society expects human engineers to be accountable for medical device safety. Clinicians, hospitals, and patients expect a human behind the software controlling their pacemaker, insulin pump, or diagnostic AI. Cultural trust in medical technology requires human accountability. Industry is adopting AI tools for productivity but not for autonomous safety decisions. |
| Total | 6/10 |
AI Growth Correlation Check
Confirmed at +1 (Weak Positive). The FDA has cleared approximately 1,000 AI/ML-enabled medical devices, and SaMD is the fastest-growing device category. Each AI-powered medical device requires IEC 62304-compliant software development, ISO 14971 risk management, and FDA submission — all performed by medical device software engineers. AI adoption in healthcare creates more regulated software, not less. However, the role is not defined by AI — traditional medical device software (embedded controllers, clinical systems, diagnostic equipment) remains the majority of work. Weak positive, not Accelerated Green.
JobZone Composite Score (AIJRI)
| Input | Value |
|---|---|
| Task Resistance Score | 3.75/5.0 |
| Evidence Modifier | 1.0 + (5 x 0.04) = 1.20 |
| Barrier Modifier | 1.0 + (6 x 0.02) = 1.12 |
| Growth Modifier | 1.0 + (1 x 0.05) = 1.05 |
Raw: 3.75 x 1.20 x 1.12 x 1.05 = 5.2920
JobZone Score: (5.2920 - 0.54) / 7.93 x 100 = 59.9/100
Zone: GREEN (Green >=48, Yellow 25-47, Red <25)
Sub-Label Determination
| Metric | Value |
|---|---|
| % of task time scoring 3+ | 30% |
| AI Growth Correlation | 1 |
| Sub-label | Green (Transforming) — >=20% task time scores 3+, Growth Correlation < 2 |
Assessor override: None — formula score accepted. The 59.9 calibrates well: 5.8 points above Firmware Engineer (54.1), justified by significantly stronger regulatory barriers (6/10 vs 3/10) and positive growth correlation (+1 vs 0). Slightly lower task resistance (3.75 vs 3.80) reflects that medical device software is less hardware-dependent than firmware, but the barrier and growth advantages more than compensate. The 11.9-point margin above the Green/Yellow boundary provides strong clearance.
Assessor Commentary
Score vs Reality Check
The 59.9 score sits comfortably in the Green zone, 11.9 points above the boundary. This is not borderline. The regulatory barrier score of 6/10 is the primary differentiator from general software engineering — IEC 62304, FDA QSR, and ISO 14971 create structural requirements for human accountability that cannot be automated away regardless of AI capability. The liability barrier (2/2) is particularly strong: medical device recalls, FDA enforcement actions, and potential criminal liability under the Park Doctrine mean a human must be personally accountable. Unlike firmware's hardware moat, this role's moat is regulatory-legal — arguably more durable because it is structural rather than temporal.
What the Numbers Don't Capture
- Regulatory complexity is increasing, not decreasing. The EU AI Act classifies healthcare AI as high-risk, adding new compliance layers. FDA's evolving AI/ML guidance creates new validation requirements. The IEC 81001-5-1 cybersecurity standard adds further demands. Each new regulation creates more work for medical device software engineers, not less.
- SaMD category growth masks traditional device stability. The headline growth in AI/ML medical devices is real but represents an additive layer. Traditional embedded medical device software (Class II/III devices) continues at steady state. The combined demand is stronger than either alone suggests.
- Bimodal documentation risk. The 30% of task time scoring 3+ (lifecycle documentation, traceability) is the most AI-amenable portion. If AI documentation tools mature to production quality with regulatory acceptance, this portion could trend toward 4, reducing task resistance. The score captures the 2026 snapshot — monitor FDA acceptance of AI-generated documentation.
Who Should Worry (and Who Shouldn't)
If you own risk management files, make safety classification decisions, lead V&V for Class C software, or manage FDA submissions — you are more protected than even the Green label suggests. Your daily work involves irreducible clinical-engineering judgment that carries personal accountability. No AI tool can bear liability for a patient safety decision.
If you primarily write application code for Class A SaMD following patterns established by senior engineers, without deep involvement in risk management or regulatory submissions — your position is more AI-amenable. AI code generation handles well-documented clinical software patterns increasingly well, and your work approaches general mid-level software engineering without the regulatory moat.
The single biggest separator: regulatory accountability. The medical device software engineer who signs design review records, owns FMEA worksheets, and appears on FDA submission cover letters is in a fundamentally different position from the one who writes code within an already-defined safety architecture. Same job title, different AI exposure.
What This Means
The role in 2028: The mid-senior medical device software engineer uses AI for code generation, automated test case creation, documentation drafting, and traceability matrix population — what took a week of documentation now takes two days. AI-powered validation tools catch coding standard violations and suggest risk mitigations. But the engineer still classifies software safety under IEC 62304, makes clinical risk acceptability judgments under ISO 14971, reviews V&V evidence against clinical intent, and signs design control records that the FDA audits. Teams of 5 do what 6 did in 2024. New work emerges: validating AI/ML algorithms embedded in medical devices, ensuring continuous learning systems remain safe, and navigating the EU AI Act's high-risk requirements.
Survival strategy:
- Deepen regulatory expertise beyond IEC 62304. Master ISO 14971 risk management, FDA AI/ML guidance, EU AI Act high-risk classification, and IEC 81001-5-1 cybersecurity. The regulatory framework is your structural moat — the more standards you command, the more irreplaceable you become.
- Build AI/ML validation capability. Learn how to validate machine learning models in a regulated context — bias testing, distribution drift monitoring, clinical performance evaluation. This is the fastest-growing sub-role and commands salary premiums.
- Embrace AI development tools for productivity. Use Copilot and AI documentation assistants for the mechanical portions — boilerplate code, template population, traceability linking. The productivity gains let you focus on the clinical judgment and regulatory accountability that AI cannot do.
Timeline: 3-5 years for significant daily workflow transformation through AI-assisted documentation and code generation. No displacement timeline — the regulatory accountability moat is structural (legal/regulatory, not technological), and SaMD growth creates net new demand. The role transforms but grows.
